FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma

Figure 3

The coexpression analysis of FCGBP in OSCC samples. (a) FCGBP expression was positively associated with CD1A, CD207, FCER1A, HLA-DQB2, and S100B. (b) Circle graph was established.

(a)

(b)